These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27499889)

  • 1. The molecular background of mucinous carcinoma beyond MUC2.
    Hugen N; Simons M; Halilović A; van der Post RS; Bogers AJ; Marijnissen-van Zanten MA; de Wilt JH; Nagtegaal ID
    J Pathol Clin Res; 2015 Jan; 1(1):3-17. PubMed ID: 27499889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous colorectal adenocarcinoma: clinical pathology and treatment options.
    Luo C; Cen S; Ding G; Wu W
    Cancer Commun (Lond); 2019 Mar; 39(1):13. PubMed ID: 30922401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum.
    Kim DH; Kim JW; Cho JH; Baek SH; Kakar S; Kim GE; Sleisenger MH; Kim YS
    Int J Oncol; 2005 Oct; 27(4):957-64. PubMed ID: 16142311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics.
    Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS
    Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signet ring cell differentiation in mucinous colorectal carcinoma.
    Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
    J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?
    Tozawa E; Ajioka Y; Watanabe H; Nishikura K; Mukai G; Suda T; Kanoh T; Hatakeyama K
    Pathol Res Pract; 2007; 203(8):567-74. PubMed ID: 17679024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into mucinous colorectal carcinoma: clues from etiology.
    Hugen N; van Beek JJ; de Wilt JH; Nagtegaal ID
    Ann Surg Oncol; 2014 Sep; 21(9):2963-70. PubMed ID: 24728741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects.
    Debunne H; Ceelen W
    Acta Chir Belg; 2013; 113(6):385-90. PubMed ID: 24494463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
    Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
    Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.
    Huang A; Yang Y; Shi JY; Li YK; Xu JX; Cheng Y; Gu J
    World J Gastrointest Surg; 2021 Dec; 13(12):1567-1583. PubMed ID: 35070064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review.
    O'Connell E; Reynolds IS; McNamara DA; Burke JP; Prehn JHM
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary.
    Hanski C; Hofmeier M; Schmitt-Gräff A; Riede E; Hanski ML; Borchard F; Sieber E; Niedobitek F; Foss HD; Stein H; Riecken EO
    J Pathol; 1997 Aug; 182(4):385-91. PubMed ID: 9306958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite-unstable mucinous colorectal carcinoma occurring in the elderly: comparison with medullary type poorly differentiated adenocarcinoma.
    Arai T; Kasahara I; Sawabe M; Kanazawa N; Kuroiwa K; Honma N; Aida J; Takubo K
    Pathol Int; 2007 Apr; 57(4):205-12. PubMed ID: 17316416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer.
    Tanaka H; Deng G; Matsuzaki K; Kakar S; Kim GE; Miura S; Sleisenger MH; Kim YS
    Int J Cancer; 2006 Jun; 118(11):2765-71. PubMed ID: 16381005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
    Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
    Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
    Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
    Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
    J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.